(Press-News.org) Research from the University of Melbourne has shown that two different vaccine viruses- used simultaneously to control the same condition in chickens- have combined to produce new infectious viruses, prompting early response from Australia's veterinary medicines regulator.
The vaccines were used to control infectious laryngotracheitis (ILT), an acute respiratory disease occurring in chickens worldwide. ILT can have up to 20% mortality rate in some flocks and has a significant economic and welfare impact in the poultry industry.
The research found that when two different ILT vaccine strains were used in the same populations, they combined into two new strains (a process known as recombination), resulting in disease outbreaks.
Neither the ILT virus or the new strains can be transmitted to humans or other animals, and do not pose a food safety risk.
The study was led by Dr Joanne Devlin, Professor Glenn Browning and Dr Sang-Won Lee and colleagues at the Asia-Pacific Centre for Animal Health at the University of Melbourne and NICTA's Victoria Research Laboratory and is published today [13 July, 2012] in the international journal Science.
Dr Devlin said the combining of live vaccine virus strains outside of the laboratory was previously thought to be highly unlikely, but this study shows that it is possible and has led to disease outbreaks in poultry flocks.
"We alerted the Australian Pesticide and Veterinary Medicines Authority (APVMA) to our findings and they are now working closely with our research team, vaccine registrants and the poultry industry to determine both short and long term regulatory actions," she said.
"Short-term measures include risk assessment of all live virus vaccines currently registered by the APVMA in regard to the risk of recombination and could include changes to product labels, which may result in restrictions on the use of two vaccines of different origins in the one animal population."
The ILT vaccines are 'live attenuated vaccines', which means that the virus has some disease-causing factors removed but the immune system still recognises the virus to defend against a real infection.
"Live vaccines are used throughout the world to control ILT in poultry. For over 40 years the vaccines used in Australia were derived from an Australian virus strain. But following a vaccine shortage another vaccine originating from Europe was registered in 2006 and rapidly became widely used," Dr Devlin said.
"Shortly after the introduction of the European strain of vaccine, two new strains of ILT virus were found to be responsible for most of the outbreaks of disease in New South Wales and Victoria. So we sought to examine the origin of these two new strains."
The team sequenced all of the genes (the genome) of the two vaccines used in Australia, and the two new outbreak strains of the virus. Following bioinformatic analysis on the resulting DNA sequence, in conjunction with Dr John Markham at NICTA's Victoria Research Laboratory, they found that the new disease-causing strains were combinations of the Australian and European origin vaccine strains.
"Comparisons of the vaccine strains and the new recombinant strains have shown that both the recombinant strains cause more severe disease, or replicate to a higher level than the parent vaccine strains that gave rise to them," Dr Lee said.
Professor Glenn Browning said recombination was a natural process that can occur when two viruses infect the same cell at the same time.
"While recombination has been recognised as a potential risk associated with live virus vaccines for many years, the likelihood of it happening in viruses like this in the field has been thought to be so low that it was considered to be very unlikely to lead to significant problems," he said.
"Our studies have shown that the risk of recombination between different vaccine strains in the field is significant as two different recombinant viruses arose within a year. We also demonstrated that the consequences of such recombination can be very severe, as the new viruses have been responsible for the deaths of thousands of Australian poultry."
"The study suggests that regulation of live attenuated vaccines for all species needs to take into account the real potential for vaccine viruses to combine. Measures such as those now being taken for the ILT vaccines will need to be implemented."
###
For more information:
Graphic on virus recombination is also available at http://flickr.com/gp/aussmc/48N2a4, credit is the Australian Science Media Centre.
Dr Joanne Devlin, Asia-Pacific Centre for Animal Health, University of Melbourne, +61 3 9035 8110, E: devlinj@unimelb.edu.au
Professor Glenn Browning, Asia-Pacific Centre for Animal Health, University of Melbourne, +61383447342, E: glenfb@unimelb.edu.au
Nerissa Hannink (Media Office), P: +613 8344 8151, M: +61 430 588 055, E: nhannink@unimelb.edu.au
For comment on the regulatory issues for veterinary medicines:
Susan Whitbread, Public Affairs Manager, APVMA, P +61 2 6210 4812, M: +61 439 401 569
Susan.whitbread@apvma.gov.au
For comment on the regulatory issues for human medicines:
Media Unit, Department of Health and Ageing, P: +61 2 6289 7400 (diverts to mobile)
news@health.gov.au
Veterinary vaccines found to combine into new viruses, prompting regulatory response
2012-07-13
ELSE PRESS RELEASES FROM THIS DATE:
UGA study shows why hypertension increases damage to eyes of diabetic patients
2012-07-13
Thursday, July 12, 2012
Athens, Ga. – Hypertension frequently coexists in patients with diabetes. A new University of Georgia study shows why the co-morbid conditions can result in impaired vision.
"Results showed early signals of cell death in eyes from diabetic animals within the first six weeks of elevated blood pressure. Later, the tiny blood vessels around the optic nerve that nourish the retina and affect visual processing showed signs of decay as early as 10 weeks after diabetic animals develop hypertension," said Azza El-Remessy, assistant professor in the ...
Controlling inflammatory and immune responses
2012-07-13
Researchers at the IRCM, led by geneticist Dr. Jacques Drouin, recently defined the interaction between two essential proteins that control inflammation. This important breakthrough will be published in tomorrow's print edition of the scientific journal Molecular Cell.
IRCM scientists study glucocorticoids, a class of steroid hormones that suppress the immune system and reduce inflammation. They are used in medicine to treat diseases such as allergies, asthma, and autoimmune diseases.
"In molecular biology and genetics, proteins known as transcription factors bind ...
Researchers create highly conductive and elastic conductors using silver nanowires
2012-07-13
Researchers from North Carolina State University have developed highly conductive and elastic conductors made from silver nanoscale wires (nanowires). These elastic conductors could be used to develop stretchable electronic devices.
Stretchable circuitry would be able to do many things that its rigid counterpart cannot. For example, an electronic "skin" could help robots pick up delicate objects without breaking them, and stretchable displays and antennas could make cell phones and other electronic devices stretch and compress without affecting their performance. However, ...
Keeping electric vehicle batteries cool
2012-07-13
Batteries provide the "fuel" that drives electric cars – in effect, the vehicles' lifeblood. If batteries are to have a long service life, overheating must be avoided. A battery's "comfort zone" lies between 20°C and 35°C. But even a Sunday drive in the midday heat of summer can push a battery's temperature well beyond that range. The damage caused can be serious: operating a battery at a temperature of 45°C instead of 35°C halves its service life. And batteries are expensive – a new one can cost as much as half the price of the entire vehicle. That is why it is so important ...
Is acetazolamide effective and safe for preventing acute mountain sickness?
2012-07-13
New Rochelle, NY, July 12, 2012 –Although acetazolamide is widely prescribed to prevent and treat acute mountain sickness (AMS), the appropriate dose at which it is effective and safe has not been clearly defined. A comprehensive review and meta-analysis of 24 studies comparing the efficacy and risks associated with increasing doses of acetazolamide is published in High Altitude Medicine & Biology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com). The article is available free online at the High Altitude Medicine & Biology (http://www.liebertpub.com/ham) ...
Why did Steve Job's death affect people who never knew him?
2012-07-13
New Rochelle, NY, July 12, 2012—The profound sense of loss and public mourning that followed the death of Apple co-founder Steve Jobs was a reflection of how great an impact he had on society and on the lives of individuals through the technology he helped to create. The magnitude and reasons for the outpouring of emotion upon his death by people who did not know him personally are explored in an article in Cyberpsychology, Behavior, and Social Networking, a peer-reviewed journal published by Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com). The article is ...
Stimulant marketed as 'natural' in sports supplement actually of synthetic origin
2012-07-13
A new study published in the journal Drug Testing and Analysis found that DMAA, a stimulant often found in many nutritional and sports supplements, does not originate from natural substances and is actually comprised of synthetic compounds.
The substance DMAA (1,3-dimethylamylamine) is a stimulant existing in various pre-workout supplements and often labeled as part of geranium plants. The safety and origin of DMAA in these supplements is often the subject of intense debate and has been recently linked to the death of two U.S. soldiers, causing the Army to pull the supplement ...
Caterpillar gets more from its food when predator is on the prowl
2012-07-13
WEST LAFAYETTE, Ind. - Animals that choose to eat in the presence of a predator run the risk of being eaten themselves, so they often go into a defensive mode and pay a physical penalty for the lack of nutrients.
But that's not so for the crop pest hornworm caterpillar, a study shows.
While other animals increase metabolism and stop growing or developing during a defensive period, hornworm caterpillars slow or stop eating but actually keep up their weight and develop a little faster in the short term. Ian Kaplan, a Purdue University assistant professor of entomology; ...
Disentangling information from photons
2012-07-13
Theoretical physicist Filippo Miatto and colleagues from the University of Strathclyde, Glasgow, UK, have found a new method of reliably assessing the information contained in photon pairs used for applications in cryptography and quantum computing. The findings, published in EPJ D¹, are so robust that they enable access to the information even when the measurements on photon pairs are imperfect.
The authors focused on photon pairs described as being in a state of quantum entanglement: i.e., made up of many superimposed pairs of states. This means that these photon pairs ...
Study questions whether becoming a doctor pays off for women
2012-07-13
Women who go to medical school just for the financial rewards of being a doctor could be making a mistake, according to a study published in the Journal of Human Capital.
The research found that after factoring in the high upfront costs of becoming a doctor, most women primary-care doctors would have made more money over their careers becoming physician assistants instead. For the median man on the other hand, becoming a doctor pays a substantial premium over becoming a PA.
Two factors drive the results, say the study's authors, M. Keith Chen and Judith Chevalier ...